Field-of-Use Restrictions in Patent Licenses

What a Field-of-Use Restriction Does

A field-of-use restriction is a clause in a patent license that limits the licensee’s authorized use of the licensed technology to a specific application, market, or product category, rather than granting rights to the invention across every possible use. Instead of asking “can Company X practice this patent,” a field-restricted license asks the narrower question “can Company X practice this patent for the purpose of making diagnostic devices” (or agricultural equipment, or industrial coatings, or whatever field the parties define).

The underlying legal mechanism is well established: a patent owner does not have to license the whole of its exclusive rights at once, and can instead grant separate, narrower slices of those rights to different parties. In the United States, this practice was upheld by the Supreme Court in General Talking Pictures Corp. v. Western Electric Co. (1938), which confirmed that a patent owner may lawfully restrict a licensee to a defined field, and that a licensee operating outside that field is an infringer rather than merely a breaching licensee. Exceeding the authorized field is patent infringement, not just a contract breach.

Why University Technology Transfer Offices Use Field-of-Use Restrictions

A single piece of foundational university IP — a platform chemistry, a diagnostic biomarker, a sensor technology, a software algorithm — frequently has applications across markets that have nothing to do with one another commercially. A gene-editing method might be relevant to human therapeutics, agricultural biotechnology, and industrial enzyme production. A materials-science discovery might apply to batteries, coatings, and medical implants. No single licensee is typically positioned (financially, operationally, or strategically) to develop and commercialize an invention across all of those markets at once.

Field-of-use restrictions let a university technology transfer office (TTO) license the same underlying patent to multiple, non-competing licensees, each confined to its own field, rather than granting one company exclusive rights to the invention in its entirety. For the university this typically means:

Broader development of the technology. Each field-restricted licensee is incentivized to invest in developing and commercializing the invention within its own market, rather than one licensee sitting on rights to fields it has no intention of pursuing (sometimes called “shelving”).
Diversified and potentially larger aggregate revenue. Royalty and milestone income can be collected from several licensees across several fields instead of a single exclusive deal, though this must be weighed against the administrative cost of managing multiple relationships (see License Agreement Structure for how royalty and milestone terms are typically built).
A closer match between the scope of exclusivity and the licensee’s actual capability. A licensee is far more willing to accept — and a university is more willing to grant — a strong exclusive position within a narrowly defined field than an unrestricted exclusive across every conceivable use, which the university would otherwise be reluctant to sign away entirely.
Retained flexibility to fulfill the university’s own mission obligations. Most university licenses, exclusive or not, carry a standing reservation of rights for the institution’s own continued research, scholarship, and teaching use of the licensed IP, regardless of what field has been licensed out commercially. This reserved-rights principle is separate from, but often sits alongside, field-of-use scoping in the same license.

This is also why field-of-use restrictions interact directly with Bayh-Dole obligations for federally funded inventions: a university retains march-in and government-use rights across the entire invention regardless of how it has fielded out commercial licenses (see CASRAI’s Government-Use License Under 28 U.S.C. § 1498 vs. Bayh-Dole March-In Rights guide), and Bayh-Dole’s “practical application” requirement is commonly assessed field by field when a technology has been licensed non-exclusively or across multiple fields.

How Fields Get Defined

There is no single accepted taxonomy for a “field” — definitions are negotiated and drafted case by case, and how tightly or loosely a field is drawn is one of the most consequential choices in the whole agreement. Fields are commonly defined along one or more of these axes:

By application or end use — e.g., “human therapeutic use,” “veterinary use,” “in vitro diagnostic use,” “research use only.” This is the most common approach for life-science and biotech licenses.
By product category or industry — e.g., “automotive,” “consumer electronics,” “industrial coatings.”
By channel or customer type — e.g., a chemical sold to agricultural customers versus consumer/retail customers is a textbook example used in patent-licensing commentary of how the same underlying product can be fielded differently depending on who buys it.
By combination with excluded uses — some licenses define the field affirmatively and then explicitly carve out excluded applications (most commonly reserving human therapeutic or diagnostic use, or defense/government applications) to avoid ambiguity at the boundary.

Field definitions are frequently paired with, but are conceptually distinct from, other scope-limiting mechanisms in the same license: territorial restrictions (where the license applies geographically), and the exclusive/non-exclusive/co-exclusive designation (who else can practice the same field). A license can be exclusive within a narrow field and still leave the university free to license other fields to other parties — these are independent dials the parties are negotiating, not one setting. See License Agreement Structure and Patent Licensing: Exclusive Terms, Royalties, and Startup vs. Established Deals for how field scope fits alongside these other grant terms.

Where Field-of-Use Negotiations Get Contested

Because the field definition is what actually delineates the licensee’s commercial exclusivity, it is routinely one of the most heavily negotiated sections of a university license, and disputes tend to cluster around a recurring set of tension points:

Scope creep at the boundary

Licensees generally want fields defined broadly enough to cover adjacent products they may develop later, or ambiguously enough that they can argue a new product falls inside the existing grant without renegotiating. Universities generally want fields defined narrowly and specifically enough that the licensee cannot credibly claim rights to a field it never invested in developing, and precisely enough to be unambiguous if it is ever litigated. Loosely drafted field language (e.g., relying on broad terms like “medical use” without specifying human versus veterinary, diagnostic versus therapeutic, or research versus commercial) is a well-documented source of later disputes, since the field definition is what a court or arbitrator will ultimately have to construe if the parties disagree about whether a given product falls inside or outside it.

New fields discovered after signing

Technologies frequently turn out to have commercially valuable applications nobody anticipated at signing. Licenses need to address, in advance, what happens when a genuinely new field emerges: does it default to the university (available to license separately), does the existing licensee get a right of first negotiation or first refusal to expand into it, or is it deemed automatically included under a broadly drafted existing field? Silence on this point is itself a common source of later friction.

Diligence and field forfeiture

Because field restrictions are the university’s tool for making sure each licensed field is actually being developed, university licenses routinely pair field-of-use grants with diligence obligations (development milestones, minimum royalties, or commercialization timelines) specific to that field, plus a mechanism — often a field-by-field termination or conversion-to-non-exclusive right — that lets the university reclaim or re-license an unexploited field if the licensee is not actually developing it. Negotiating how strict those diligence triggers are, and how much cure period a licensee gets before losing a field, is a recurring point of tension.

Sublicensing across field boundaries

A licensee that wants to sublicense (e.g., to a distribution partner, a co-development partner, or a downstream manufacturer) raises the question of whether the sublicense can extend outside the licensee’s own field, and how the university’s field boundaries are contractually flowed down and enforced against a party the university has no direct relationship with.

Reserved research, government, and nonprofit rights

Even inside an exclusively licensed field, university licenses commonly reserve continuing rights for the university (and often other nonprofit/academic institutions generally) to use the invention for internal research, scholarship, and teaching purposes, and rights necessary to satisfy federal funding obligations. Negotiating exactly how that reservation is worded — broad enough to protect academic freedom and compliance obligations, narrow enough that it does not functionally undercut the licensee’s exclusivity — is a standard, recurring negotiation point rather than boilerplate that gets waved through.

Antitrust exposure at the outer edge

Field-of-use licensing is lawful and routine, but courts have distinguished between a licensor legitimately segmenting fields to match different licensees’ capabilities and licensors or licensees using field restrictions to divide markets or fix prices among what are, in substance, competitors — the latter can raise antitrust concerns, as in the Supreme Court’s Hartford-Empire Co. v. United States decision, which addressed a field-of-use licensing arrangement found to function as market allocation. This is a background legal risk a TTO’s counsel screens for rather than a routine drafting concern in an ordinary single-university, single-licensee deal, but it is part of why field definitions and any related restrictions get legal review rather than being treated as purely commercial terms.

Drafting Field Definitions Well

Because field-of-use language becomes the operative boundary of the license, practitioners generally treat precision as more important than breadth. Recurring drafting practices worth knowing, without claiming any specific clause is universal or standard-form:

Define the field by objective, verifiable criteria (a regulatory category, an industry classification, an intended use as stated on labeling or regulatory filings) rather than subjective or aspirational language, so that whether a given product is “in” or “out” of the field can be determined without relitigating intent.
State explicitly whether the field is defined by the licensee’s use of the technology or by the end product’s characteristics — these can diverge (e.g., the same compound formulated identically might be sold into two different fields depending on the label and marketing claims attached to it).
Address field expansion mechanics up front (new-field procedures, rights of first negotiation/refusal) rather than leaving them to be negotiated from scratch if and when a new field materializes.
Tie field-specific diligence milestones and reversion/termination rights directly to the field definition, so the university has a concrete, field-by-field remedy if a licensed field goes undeveloped.
Cross-reference the field definition consistently throughout the agreement — in the grant clause, the royalty/milestone schedule, the sublicensing clause, and any most-favored-licensee or diligence provisions — since an inconsistency between how the field is defined in different sections of the same license is a common source of later interpretive disputes.

Because the exact wording of a workable field definition is highly technology- and industry-specific, and because getting it wrong has real infringement and antitrust consequences, university licensing offices typically draft and negotiate this language with legal counsel rather than relying on a generic template, and specific clause language should not be treated as a universal standard.

Frequently Asked Questions

What’s the difference between a field-of-use restriction and a territorial restriction?

A field-of-use restriction limits what the licensee can do with the patent (which application or market); a territorial restriction limits where the licensee can do it (which country or region). The two are independent and are routinely combined in the same license — a licensee might hold an exclusive field-of-use license for “veterinary diagnostics” limited to North America, for example.

Can a licensee be exclusive and field-restricted at the same time?

Yes — these are separate dimensions of the grant. A license can be exclusive (no one else, including the university, can practice the licensed rights) within a narrowly defined field, while the university remains free to license, or continue practicing itself, in every field outside that definition.

What happens if a licensee’s product doesn’t clearly fall inside or outside the defined field?

This is the scenario well-drafted field language is meant to prevent, but it does happen, and it is typically resolved first through the agreement’s dispute-resolution or good-faith negotiation provisions, and, failing that, through litigation or arbitration in which the field definition’s actual text controls. It is a central reason licensing practitioners emphasize objective, verifiable field criteria over broad or aspirational category language.

Do field-of-use restrictions affect a university’s Bayh-Dole reporting obligations?

The invention itself, not each individual field license, is what gets tracked for Bayh-Dole utilization and march-in purposes, but “practical application” (bringing the invention to practical use on reasonable terms) is commonly assessed with reference to whichever fields have actually been licensed and developed. See CASRAI’s guide on government-use licenses and march-in rights for how those federal retained rights interact with a university’s commercial licensing program.

Field-of-Use Restrictions in University Patent Licenses: How to Draft and Negotiate Them